Intervention_type,intervention,Study_count
Drug,hydroxychloroquine,70
Drug,placebo,54
Other,placebo,28
Drug,azithromycin,23
Drug,placebo oral tablet,22
Drug,tocilizumab,16
Drug,placebos,14
Drug,hydroxychloroquine sulfate,13
Other,no intervention,13
Biological,convalescent plasma,12
Drug,remdesivir,12
Drug,lopinavir/ritonavir,11
Other,standard of care,11
Drug,favipiravir,9
Drug,methylprednisolone,8
Drug,chloroquine,7
Drug,losartan,7
Drug,ruxolitinib,7
Other,standard care,7
Drug,colchicine,6
Drug,standard of care,6
Drug,anakinra,5
Drug,sarilumab,5
Other,questionnaire,5
Biological,uc-mscs,4
Dietary Supplement,vitamin c,4
Dietary Supplement,vitamin d,4
Drug,hydroxychloroquine + azithromycin,4
Drug,nitazoxanide,4
Other,blood sample,4
Other,questionnaire assesment,4
Other,usual care,4
Biological,anti-sars-cov-2 convalescent plasma,3
Biological,placebo,3
Diagnostic Test,covid-19 rt-pcr,3
Diagnostic Test,lung ultrasound,3
Drug,baricitinib,3
Drug,camostat mesilate,3
Drug,chloroquine or hydroxychloroquine,3
Drug,clazakizumab,3
Drug,colchicine tablets,3
Drug,hydroxychloroquine (hcq),3
Drug,interferon beta-1a,3
Drug,interferon beta-1b,3
Drug,lopinavir / ritonavir,3
Drug,methotrexate,3
Drug,nitric oxide gas,3
Drug,oseltamivir,3
Drug,suspension of heat killed (autoclaved) mycobacterium w,3
Other,telemedicine,3
Other,telerehabilitation,3
Biological,mscs,2
Biological,recombinant novel coronavirus vaccine (adenovirus type 5 vector),2
Device,hyperbaric oxygen therapy,2
Diagnostic Test,nasopharyngeal swab,2
Diagnostic Test,online questionnaire,2
Dietary Supplement,sivomixx (200 billion),2
Dietary Supplement,zinc,2
Dietary Supplement,zinc gluconate,2
Drug,abidol hydrochloride,2
Drug,ace inhibitor,2
Drug,arbidol,2
Drug,ascorbic acid,2
Drug,azithromycin tablets,2
Drug,bcg vaccine,2
Drug,bevacizumab injection,2
Drug,chloroquine diphosphate,2
Drug,chloroquine phosphate,2
Drug,chloroquine sulfate,2
Drug,das181,2
Drug,deferoxamine,2
Drug,dexamethasone,2
Drug,dexamethasone injection,2
Drug,dornase alfa inhalation solution [pulmozyme],2
Drug,eculizumab,2
Drug,emtricitabine/tenofovir disoproxil,2
Drug,enoxaparin,2
Drug,hb-admscs,2
Drug,hydrocortisone,2
Drug,hydroxychloroquine - daily dosing,2
Drug,hydroxychloroquine - weekly dosing,2
Drug,hydroxychloroquine + placebo,2
Drug,hydroxychloroquine sulfate 200 mg,2
Drug,hydroxychloroquine sulfate loading dose,2
Drug,hydroxychloroquine sulfate regular dose,2
Drug,ivermectin,2
Drug,l-ascorbic acid,2
Drug,leronlimab (700mg),2
Drug,nitric oxide,2
Drug,nivolumab,2
Drug,nors (nitric oxide releasing solution),2
Drug,peginterferon lambda-1a,2
Drug,placebo: hydroxychloroquine,2
Drug,plasma,2
Drug,povidone-iodine nasal spray and gargle,2
Drug,prednisone,2
Drug,pul-042 inhalation solution,2
Drug,remdesivir placebo,2
Drug,ruxolitinib oral tablet,2
Drug,selinexor,2
Drug,sevoflurane,2
Drug,siltuximab,2
Drug,single dose of hydroxychloroquine,2
Drug,standard treatment,2
Drug,telmisartan,2
Drug,thalidomide,2
Drug,tocilizumab (tcz),2
Drug,tocilizumab injection,2
Other,blood draw,2
Other,blood sampling,2
Other,convalescent plasma,2
Other,exercise brochure,2
Other,follow up,2
Other,observational,2
Other,other,2
Other,pregnant women with laboratory-confirmed 2019-n-cov,2
Other,questionnaires,2
Other,retrospective analysis,2
Other,self-administered questionnaire,2
Other,standard treatment,2
Other,survey,2
Procedure,prone positioning,2
Behavioral,1: prone positioning,1
Behavioral,2: no instruction regarding positioning,1
Behavioral,assessment of behavioral response to emotional stimulation,1
Behavioral,assessment of work-related stress,1
Behavioral,attention bias modification (abm),1
Behavioral,behavioral: ocat,1
Behavioral,behavioral: ocat-sham,1
Behavioral,burnout,1
Behavioral,covid-surgres questionaire,1
Behavioral,crisis management coaching,1
Behavioral,enhanced hygiene measures,1
Behavioral,general health education,1
Behavioral,guided online support program,1
Behavioral,health care worker survey,1
Behavioral,humanistic care,1
Behavioral,intermittent prone positioning instructions,1
Behavioral,internet-delivered cognitive behavior therapy (icbt) for dysfunctional worry related to the covid-19 pandemic,1
Behavioral,mindfulness session(s),1
Behavioral,observation of behavior and covid-19 infection will be conducted.,1
Behavioral,online bibliotherapy programme,1
Behavioral,online cognitive behavioral therapy (cbt),1
Behavioral,online mindfulness group,1
Behavioral,online survey,1
Behavioral,personalized health education,1
Behavioral,phone-call screening and management by a medical student/general practitioner tandem,1
Behavioral,prayer,1
Behavioral,psychological and physical rehabilitation based humanistic care,1
Behavioral,psychological assessment,1
Behavioral,ptsd,1
Behavioral,social media & news consumption,1
Behavioral,tele-interventions related to diabetes management and mental well-being,1
Behavioral,turkish physicians,1
Behavioral,usual care positioning with no instructions,1
Behavioral,video based exercise,1
Behavioral,who recommendations (waiting condition),1
Biological,2019-ncov pcr,1
Biological,allogeneic human dental pulp stem cells (bsh btc & utooth btc),1
Biological,allogeneic nk transfer,1
Biological,anakinra,1
Biological,anti- sars-cov-2 plasma,1
Biological,anti-coronavirus antibodies (immunoglobulins)obtained with dfpp from convalescent patients,1
Biological,autologous adipose msc's,1
Biological,bactek-r,1
Biological,bactrl-spike,1
Biological,bcg vaccine,1
Biological,biological collection (patients co infected hiv sras-cov-2),1
Biological,biological test,1
Biological,biological: covid-19 convalescent plasma,1
Biological,blood plasma,1
Biological,blood samples,1
Biological,blood sampling,1
Biological,blood test,1
Biological,bm-mscs,1
Biological,cap-1002 allogeneic cardiosphere-derived cells,1
Biological,castem,1
Biological,cell therapy protocol 1,1
Biological,cell therapy protocol 2,1
Biological,chadox1 ncov-19,1
Biological,chadox1 ncov-19 boost,1
Biological,collection of biological samples,1
Biological,convalescent anti-sars-cov-2 plasma,1
Biological,convalescent covid 19 plasma,1
Biological,convalescent plasma (anti-sars-cov-2 plasma),1
Biological,covid-19 convalescent plasma,1
Biological,covid-19 exposure,1
Biological,cynk-001,1
Biological,dental pulp mesenchymal stem cells,1
Biological,eculizumab,1
Biological,emapalumab,1
Biological,evaluation of blood results of covid 19 positive pregnant patients,1
Biological,high-titer anti-sars-cov-2 plasma,1
Biological,high-titer covid-19 convalescent plasma (ht-ccp),1
Biological,human amniotic fluid,1
Biological,hyperimmune plasma,1
Biological,"ic14, a monoclonal antibody against cd14",1
Biological,injection and infusion of lv-smenp-dc vaccine and antigen-specific ctls,1
Biological,intradermal injection of bcg vaccine,1
Biological,lactated ringer's solution or sterile saline,1
Biological,lenzilumab,1
Biological,menacwy,1
Biological,mesenchymal cells,1
Biological,mesenchymal stromal cells,1
Biological,mrna-1273,1
Biological,mscs-derived exosomes,1
Biological,multiple doses of anti-sars-cov-2 convalescent plasma,1
Biological,multistem,1
Biological,nasopharyngeal swab,1
Biological,nestcellâ®,1
Biological,nk cells,1
Biological,"nk cells,il15-nk cells,nkg2d car-nk cells,ace2 car-nk cells,nkg2d-ace2 car-nk cells",1
Biological,non-convalescent plasma (control plasma),1
Biological,pathogen-specific aapc,1
Biological,pathogen reduced sars-cov-2 convalescent plasma,1
Biological,pembrolizumab (mk-3475),1
Biological,placebo vaccine,1
Biological,plasma,1
Biological,rectal swab,1
Biological,saline containing 1% human serum albuminï¼ˆsolution of mscï¼‰,1
Biological,saliva sample,1
Biological,saliva sample collection,1
Biological,sarilumab,1
Biological,sars-cov-2 non-immune plasma,1
Biological,serological test,1
Biological,serology test,1
Biological,serum test,1
Biological,standard donor plasma,1
Biological,standard plasma,1
Biological,standard plasma (ffp),1
Biological,tocilizumab,1
Biological,two doses of high dosage inactivated sars-cov-2 vaccine at the emergency vaccination schedule,1
Biological,two doses of high dosage inactivated sars-cov-2 vaccine at the routine vaccination schedule,1
Biological,two doses of medium dosage inactivated sars-cov-2 vaccine at the emergency vaccination schedule,1
Biological,two doses of medium dosage inactivated sars-cov-2 vaccine at the routine vaccination schedule,1
Biological,two doses of placebo at the emergency vaccination schedule,1
Biological,two doses of placebo at the routine vaccination schedule,1
Biological,umbilical cord mesenchymal stem cells,1
Biological,umbilical cord wharton's jelly-derived human,1
Biological,vaccine bcg,1
Biological,wj-mscs,1
Combination Product,azithromycin with amoxicillin/clavulanate,1
Combination Product,hydroxychloroquine + azithromycin + / - tocilizumab,1
Combination Product,hydroxychloroquine plus nitazoxanide,1
Combination Product,hydroxychloroquine sulfate + azithromycin,1
Combination Product,hyperbaric oxygen treatment (hbot) i.e. inhalation of pressurized oxygen delivered by a hyperbaric chamber (drug/device),1
Combination Product,ivermectin plus nitazoxanide,1
Combination Product,mefloquine + azithromycin + / - tocilizumab,1
Combination Product,observational (registry),1
Combination Product,standard of care (soc),1
Combination Product,stem cell educator-treated mononuclear cells apheresis,1
Combination Product,systemic treatment,1
Device,actigraphy,1
Device,aerosol-reducing mask,1
Device,airgo respiratory monitor,1
Device,automated oxygen administration - freeo2,1
Device,bidirectional oxygenation mouthpiece,1
Device,biosensors,1
Device,biovitals,1
Device,caption ai,1
Device,cellectraâ® 2000,1
Device,centricyte 1000,1
Device,control group,1
Device,control swab,1
Device,cordio app,1
Device,coviage,1
Device,covsurf drug delivery system,1
Device,covx,1
Device,cpap treatment,1
Device,ct-imaging,1
Device,ct-v,1
Device,cytokine adsorption,1
Device,cytosorb-therapy,1
Device,double-trunk mask,1
Device,ecco2r,1
Device,echocardiography,1
Device,electric pad for human external pain therapy,1
Device,expiratory training device,1
Device,gammacoreâ® (vagus nerve stimulation),1
Device,go2 peep mouthpiece,1
Device,high flow nasal cannula (hfnc),1
Device,hyperbaric oxygen therapy (hbot),1
Device,inspiratory training device,1
Device,intraosseous access,1
Device,intravenous access,1
Device,kerecis oral and nasal spray,1
Device,magec spine rod,1
Device,medical mask,1
Device,mouthrinse with bãªta-cyclodextrin and citrox,1
Device,mouthrinse without bãªta-cyclodextrin and citrox,1
Device,multifrequency bioimpedance spectroscopy,1
Device,musclesound ultrasound,1
Device,n95 respirator,1
Device,neuromuscular evaluation,1
Device,nioâ® (intraosseous access),1
Device,non-contact ecg,1
Device,non-contact mce system,1
Device,normobaric oxygen therapy,1
Device,oxygen,1
Device,oxyhydrogen,1
Device,plasma adsorption cartridge,1
Device,prototype swab,1
Device,q-nrg metobolic cart device,1
Device,sensiumvitals wearable sensor,1
Device,seraph 100,1
Device,sledd with a l-mod,1
Device,standard mask,1
Device,standard of care (intravenous access),1
Device,tavr or savr,1
Device,toraymyxin pmx-20r (pmx cartridge),1
Device,transpulmonary thermodilution,1
Device,vivadiagâ„¢ covid-19 lgm/igg rapid test,1
Device,vv-ecmo + cytokine adsorption (cytosorb adsorber),1
Device,vv-ecmo only (no cytokine adsorption),1
Device,wearable medical device (empatica e4),1
Device,web application users,1
Diagnostic Test,a specifically designed self-administered questionnaire,1
Diagnostic Test,assessment of cardiovascular diseases and cardiovascular risk factors,1
Diagnostic Test,"biomarker (tropt, myoglobin, ck, ck-mb, ldh, d-dimer, crp, pct)",1
Diagnostic Test,biomarkers expression,1
Diagnostic Test,biosensor,1
Diagnostic Test,breath test,1
Diagnostic Test,cambridge validated viral detection method,1
Diagnostic Test,chest computed tomography (ct),1
Diagnostic Test,complement dosage,1
Diagnostic Test,conjunctival swab,1
Diagnostic Test,copan swabbing and blood sample collection,1
Diagnostic Test,coronacidetm covid-19 igm/igg rapid test and premier biotech covid-19 igm/igg rapid test,1
Diagnostic Test,covid-19 antibody testing (igg and igm),1
Diagnostic Test,covid-19 diagnostic test,1
Diagnostic Test,"covid-19 igm/igg rapid testing, mobile device image capture and telemedicine support",1
Diagnostic Test,covid-19 serology,1
Diagnostic Test,"covid-19 test, polymerase chain reaction for sars-cov-2",1
Diagnostic Test,covid 19 diagnostic test by pcr,1
Diagnostic Test,cytokine profile,1
Diagnostic Test,cytokines dosage,1
Diagnostic Test,data collection and rhinopharyngeal swab,1
Diagnostic Test,diagnostic test,1
Diagnostic Test,ecg,1
Diagnostic Test,"electrocardiogram, telemetry, echocardiogram, laboratory values",1
Diagnostic Test,"electrocardiogram, transthoracic echocardiography and clinico-biological parameters in routine care",1
Diagnostic Test,elisa-test for igm and igg to sars-cov-2,1
Diagnostic Test,euroimmun assay,1
Diagnostic Test,global longitudinal strain,1
Diagnostic Test,identify sars-cov-2 infection by serology,1
Diagnostic Test,igg,1
Diagnostic Test,igm and igg diagnostic kits to sars-cov-2,1
Diagnostic Test,laboratory biomarkers,1
Diagnostic Test,loop mediated isothermal amplification covid-19,1
Diagnostic Test,machine learning model,1
Diagnostic Test,monitoring visit - baseline,1
Diagnostic Test,monitoring visit - week 4,1
Diagnostic Test,monitoring visit - week 8,1
Diagnostic Test,monthly serologic igm/g test,1
Diagnostic Test,muscle ultrasound,1
Diagnostic Test,nasopharyngeal covid 19 rt-pcr,1
Diagnostic Test,new qiastat-dx fully automatic multiple pcr detection platform,1
Diagnostic Test,new screening strategy,1
Diagnostic Test,ng biotech,1
Diagnostic Test,no intervention planned due to the observational study design only a diagnostic testing,1
Diagnostic Test,odd/even birth year intervention groups,1
Diagnostic Test,point-of-care ultrasonography (pocus),1
Diagnostic Test,polysomnography,1
Diagnostic Test,public health england gold standard,1
Diagnostic Test,questionnaire forms,1
Diagnostic Test,radiological detection,1
Diagnostic Test,rapid salivary test,1
Diagnostic Test,recombinase aided amplification (raa) assay,1
Diagnostic Test,reverse-transcription polymerase chain reaction (rt-pcr),1
Diagnostic Test,saliva collection,1
Diagnostic Test,samba ii (diagnostic for the real world),1
Diagnostic Test,sampling salivary,1
Diagnostic Test,sars-cov-2 igg antibody testing kit,1
Diagnostic Test,sars-cov2 testing,1
Diagnostic Test,scanning chest x-rays and performing ai algorithms on images,1
Diagnostic Test,schirmer test i,1
Diagnostic Test,serological tests will be applied on patients blood sampling,1
Diagnostic Test,serology,1
Diagnostic Test,serum inflammatory biomarkers,1
Diagnostic Test,serum sars cov 2 igg screening in health care workers,1
Diagnostic Test,spartan cube point-of care covid-19 test,1
Diagnostic Test,"standard 12-lead ecg, nt-probnp, echocardiography",1
Diagnostic Test,standard screening strategy,1
Diagnostic Test,standardized lung ultrasound (lus) examination,1
Diagnostic Test,swallowing evaluation with the eat-10 and the volume-viscosity swallowing test (v-vst),1
Diagnostic Test,tem-tpa,1
Diagnostic Test,testing sensitivity for sars-cov-2 virus in symptomatic individuals,1
Diagnostic Test,thoracic ct scan,1
Diagnostic Test,titanium blood test,1
Diagnostic Test,to assess for development of igg antibodies against sars-cov2,1
Diagnostic Test,tuberculin test,1
Diagnostic Test,ultrasound lung imaging as part of fast+ evaluation,1
Diagnostic Test,vitalconnect vital sign patch,1
Dietary Supplement,25-oh cholecalciferol,1
Dietary Supplement,ascorbic acid,1
Dietary Supplement,ascorbic acid and zinc gluconate,1
Dietary Supplement,ayurveda,1
Dietary Supplement,control,1
Dietary Supplement,glucose tablets,1
Dietary Supplement,isocaloric/isonutrigenous ons,1
Dietary Supplement,ketogenic diet,1
Dietary Supplement,natural honey,1
Dietary Supplement,"oral nutrition supplement (ons) enriched in eicosapentaenoic acid, gamma-linolenic acid and antioxidants",1
Dietary Supplement,placebo,1
Dietary Supplement,placebo starch,1
Dietary Supplement,probiotic,1
Dietary Supplement,vitamins,1
Drug,0.12% chlorhexidine oral/nasal rinse,1
Drug,0.5% povidone/iodine oral/nasal rinse,1
Drug,0.9% sodium chloride (normal saline),1
Drug,1: discontinuation of ras blocker therapy,1
Drug,1: ilt101,1
Drug,1: naproxen,1
Drug,100 mg/ml virazole,1
Drug,2: continuation of ras blocker therapy,1
Drug,2: placebo comparator,1
Drug,2: standard of care,1
Drug,2: usual practice + symbicort rapihaler,1
Drug,50 mg/ml virazole,1
Drug,abidol hydrochloride combined with interferon atomization,1
Drug,acalabrutinib,1
Drug,"ace inhibitor, angiotensin receptor blocker",1
Drug,aceis,1
Drug,acetylsalicylic acid,1
Drug,allogeneic and expanded adipose tissue-derived mesenchymal stem cells,1
Drug,allogeneic and expanded adipose tissue-derived mesenchymal stromal cells,1
Drug,almitrine,1
Drug,alteplase 100 mg [activase],1
Drug,alteplase 50 mg [activase],1
Drug,amiodarone,1
Drug,amoxicillin/clavulanate,1
Drug,anakinra alone (stages 2b/3),1
Drug,anakinra and ruxolitinib (overcome stage 3),1
Drug,anakinra plus osoc,1
Drug,angiotensin-converting enzyme inhibitors (ace-i) and angiotensin ii receptor blockers (arb),1
Drug,angiotensin 1-7,1
Drug,angiotensin converting enzyme inhibitor,1
Drug,angiotensin receptor blocker,1
Drug,anluohuaxian,1
Drug,any drug used to treat covid-19,1
Drug,arb,1
Drug,arbidol hydrochloride granules,1
Drug,asc09/ritonavir group,1
Drug,asc09f+oseltamivir,1
Drug,ascorbic acid and folic acid,1
Drug,aspirin,1
Drug,aspirin 100mg,1
Drug,aspirin 75mg,1
Drug,aspirin 81 mg,1
Drug,at-001,1
Drug,atorvastatin 40mg,1
Drug,atovaquone/azithromycin,1
Drug,aviptadil (vip),1
Drug,aviptadil by intravenous infusion + maximal intensive care,1
Drug,avm0703,1
Drug,az,1
Drug,azithromycin (azithro),1
Drug,azithromycin 500 mg,1
Drug,azithromycin 500mg oral tablet,1
Drug,baricitinib (janus kinase inhibitor),1
Drug,baricitinib 4 mg oral tablet,1
Drug,baricitinib or anakinra,1
Drug,baricitinib oral tablet,1
Drug,basic treatment,1
Drug,bat,1
Drug,bat + calcifediol,1
Drug,best available treatment,1
Drug,best supportive care (bsc) + ifx-1,1
Drug,best supportive care only,1
Drug,bevacizumab,1
Drug,bld-2660,1
Drug,bms-986253,1
Drug,bromhexine 8 mg,1
Drug,bromhexine hydrochloride tablets,1
Drug,bromhexine oral tablet and/or hydroxychloroquine tablet,1
Drug,budesonide nasal,1
Drug,calcium channel blockers,1
Drug,canakinumab,1
Drug,canakinumab 150 mg/ml [ilaris],1
Drug,canakinumab injection 300mg,1
Drug,canakinumab injection 600mg,1
Drug,candesartan,1
Drug,captopril 25mg,1
Drug,carrimycin,1
Drug,cd24fc,1
Drug,chemotherapy,1
Drug,chlorine dioxide 3000 ppm,1
Drug,chloroquine analog (gns651),1
Drug,chlorpromazine (cpz),1
Drug,chlorpromazine injection,1
Drug,"cholecalciferol 200,000 iu",1
Drug,"cholecalciferol 50,000 iu",1
Drug,ciclesonide metered dose inhaler [alvesco],1
Drug,clazakizumab 12.5 mg,1
Drug,clazakizumab 25 mg,1
Drug,clevudine,1
Drug,clopidogrel,1
Drug,clopidogrel 75mg,1
Drug,cm4620-injectable emulsion,1
Drug,control arm,1
Drug,control group,1
Drug,convalescent plasma transfusion,1
Drug,convalescent serum,1
Drug,"conventional medicines (oxygen therapy, alfa interferon via aerosol inhalation, and lopinavir/ritonavir)",1
Drug,"conventional medicines (oxygen therapy, alfa interferon via aerosol inhalation, and lopinavir/ritonavir) and traditional chinese medicines (tcms) granules",1
Drug,conventional treatment,1
Drug,danoprevir+ritonavir,1
Drug,dapagliflozin 10 mg,1
Drug,darunavir and cobicistat,1
Drug,defibrotide 25 mg/kg 24 hours continuous infusion for 15 days,1
Drug,defibrotide injection,1
Drug,dexamethasone and hydroxychloroquine,1
Drug,dexmedetomidine injectable product,1
Drug,dietary supplement containing resistant starch,1
Drug,drug isotretinoin (13 cis retinoic acid ) capsules+standard treatment,1
Drug,eicosapentaenoic acid gastro-resistant capsules,1
Drug,enoxaparin higher dose,1
Drug,enoxaparin prefilled syringe [lovenox],1
Drug,enoxaparin prophylactic dose,1
Drug,enoxaparin/lovenox intermediate dose,1
Drug,escin,1
Drug,estradiol patch,1
Drug,etoposide,1
Drug,experimental drug,1
Drug,favipiravir + standard of care,1
Drug,favipiravir combined with tocilizumab,1
Drug,favipiravir tablets,1
Drug,favipiravir tablets+chloroquine phosphatetablets tablets,1
Drug,fingolimod 0.5 mg,1
Drug,fluvoxamine,1
Drug,fondaparinux,1
Drug,ft516,1
Drug,ganovo+ritonavir+/-interferon nebulization,1
Drug,gargle/mouthwash,1
Drug,gimsilumab,1
Drug,group a hcq,1
Drug,group b control,1
Drug,hb-admsc,1
Drug,hc,1
Drug,hcq,1
Drug,hcq & az,1
Drug,hcq+azt,1
Drug,heparin infusion,1
Drug,heparin sc,1
Drug,hidroxicloroquina,1
Drug,hidroxicloroquina + azitromicina o lopinavir/ritonavir + interferon î²-1b + hidroxicloroquina,1
Drug,hidroxicloroquine,1
Drug,high does chloroquine or hydroxychloroquine,1
Drug,high dose vitamin c,1
Drug,honey,1
Drug,huaier granule,1
Drug,human immunoglobulin,1
Drug,hydoxychloroquine or chloroquine,1
Drug,hydroxychloroquine 200 mg oral tablet,1
Drug,hydroxychloroquine and azithromycin treatment,1
Drug,hydroxychloroquine and azithromycin treatment arm.,1
Drug,hydroxychloroquine as post exposure prophylaxis,1
Drug,hydroxychloroquine oral product,1
Drug,hydroxychloroquine placebo,1
Drug,hydroxychloroquine plus standard preventive measures,1
Drug,hydroxychloroquine pre-exposure prophylaxis,1
Drug,hydroxychloroquine sar321068,1
Drug,hydroxychloroquine sulfate (hcq),1
Drug,hydroxychloroquine sulfate + azythromycin,1
Drug,hydroxychloroquine sulfate 200 mg [plaquenil],1
Drug,hydroxychloroquine sulfate 200 milligram (mg) tab,1
Drug,hydroxychloroquine sulfate 400 mg twice a day,1
Drug,hydroxychloroquine sulfate 600 mg once a day,1
Drug,hydroxychloroquine sulfate 600 mg twice a day,1
Drug,hydroxychloroquine sulfate and azithromycin,1
Drug,hydroxychloroquine sulfate and folic acid,1
Drug,"hydroxychloroquine, azithromycin",1
Drug,"hydroxychloroquine, clindamycin",1
Drug,"hydroxychloroquine, clindamycin, primaquine - high dose.",1
Drug,"hydroxychloroquine, clindamycin, primaquine - low dose.",1
Drug,"hydroxychloroquine, doxycycline",1
Drug,hyperbaric oxygen,1
Drug,î³-globulin,1
Drug,ibuprofen,1
Drug,imatinib,1
Drug,imatinib tablets,1
Drug,immunoglobulin of cured patients,1
Drug,indomethacin,1
Drug,inhaled budesonide,1
Drug,inhaled nitric oxide gas,1
Drug,ino-4800,1
Drug,ino (inhaled nitric oxide) delivered via the inopulse delivery system,1
Drug,insulin regimen,1
Drug,interferon-alpha2b,1
Drug,interferon-beta,1
Drug,interferon-î² 1a,1
Drug,intermediate dose thromboprophylaxis,1
Drug,intravenous drug,1
Drug,isoprinosine,1
Drug,isotonic saline 0.9%,1
Drug,isotretinoin only product in oral dose form,1
Drug,isotretinoin(aerosolized 13 cis retinoic acid) +standard treatment,1
Drug,ivermectine,1
Drug,ketamine,1
Drug,kevzara sc,1
Drug,leflunomide,1
Drug,"lenalidomide as a 5 mg capsule po daily, days 1, 3, and 5.",1
Drug,levamisole,1
Drug,levamisole and isoprinosine,1
Drug,levamisole pill + budesonide+formoterol inhaler,1
Drug,liberase enzyme (roche),1
Drug,linagliptin,1
Drug,lopinavir / ritonavir pill,1
Drug,lopinavir / ritonavir tablets combined with xiyanping injection,1
Drug,"lopinavir / ritonavir, alpha-interferon nebulization",1
Drug,lopinavir 200mg/ritonavir 50mg tab,1
Drug,lopinavir and ritonavir,1
Drug,lopinavir and ritonavir tablets,1
Drug,lopinavir/ritonavir + hydoxychloroquine,1
Drug,lopinavir/ritonavir group,1
Drug,lopinavir/ritonavir tablets or arbidol or chloroquine phosphate,1
Drug,lopinavir/ritonavir treatment,1
Drug,low-dose chloroquine/hydroxychloroquine,1
Drug,lower-dose prophylactic anticoagulation,1
Drug,ly3127804,1
Drug,mavrilimumab,1
Drug,measles-mumps-rubella vaccine,1
Drug,mefloquine,1
Drug,melatonin 2mg,1
Drug,meplazumab for injection,1
Drug,methylprednisolone 80 mg/ml injectable suspension,1
Drug,methylprednisolone sodium succinate,1
Drug,methylprednisolone therapy,1
Drug,mid dose chloroquine or hydroxychloroquine,1
Drug,mrx-4dp0004,1
Drug,n-acetylcysteine+ fuzheng huayu tablet,1
Drug,n-acetylcysteine+placebo,1
Drug,nafamostat mesilate,1
Drug,naltrexone,1
Drug,niclosamide,1
Drug,nigella sativa / black cumin,1
Drug,nintedanib 150 mg,1
Drug,nitazoxanide 500 mg,1
Drug,nitazoxanide tablets,1
Drug,nivolumab injection,1
Drug,non-ras blocking antihypertensives,1
Drug,normal saline,1
Drug,normal saline infusion + maximal intensive care,1
Drug,omeprazole 20mg,1
Drug,oral,1
Drug,osoc,1
Drug,other drugs,1
Drug,patients with the treatment agains covid19,1
Drug,pd-1 blocking antibody+standard treatment,1
Drug,peginterferon lambda alfa-1a subcutaneous injection,1
Drug,pegylated interferon lambda,1
Drug,physiological saline solution,1
Drug,piclidenoson,1
Drug,pirfenidone,1
Drug,placebo 250 cc 24 hours continuous infusion for 15 days,1
Drug,placebo for azithromycin,1
Drug,placebo for clazakizumab,1
Drug,placebo for hydroxychloroquine,1
Drug,placebo of hydroxychloroquine,1
Drug,placebo of lpv/r tablets,1
Drug,placebo oral capsule,1
Drug,placebo plus standard preventive measures,1
Drug,placebo solution,1
Drug,placebo: emtricitabine/tenofovir disoproxil,1
Drug,placebo: emtricitabine/tenofovir disoproxil placebo,1
Drug,plaquenil 200mg tablet,1
Drug,povidone-iodine 0.5%,1
Drug,povidone-iodine 2%,1
Drug,prazosin,1
Drug,progesterone 100 mg,1
Drug,propofol,1
Drug,pyridostigmine bromide,1
Drug,ramipril 2.5 mg oral capsule,1
Drug,random donor plasma,1
Drug,recombinant human angiotensin-converting enzyme 2 (rhace2),1
Drug,recombinant human interferon alpha-1b,1
Drug,recombinant human interferon î±1î²,1
Drug,recombinant human interferon î±2b spray,1
Drug,recombinant human plasma gelsolin (rhu-pgsn),1
Drug,remestemcel-l,1
Drug,rhace2 apn01,1
Drug,ribavirin,1
Drug,ritonavir+oseltamivir,1
Drug,rivaroxaban,1
Drug,rivaroxaban 2.5 mg,1
Drug,roactemra iv,1
Drug,roactemra sc,1
Drug,ruxolitinib administration,1
Drug,ruxolitinib plus simvastatin,1
Drug,saline oral/nasal rinse,1
Drug,sargramostim,1
Drug,sarilumab 200 mg/1.14 ml subcutaneous solution [kevzara],1
Drug,sarilumab 400 mg/2.28 ml subcutaneous solution [kevzara],1
Drug,sarilumab sar153191,1
Drug,sildenafil citrate tablets,1
Drug,simvastatin,1
Drug,sirolimus,1
Drug,sitagliptin,1
Drug,sodium chloride 9mg/ml,1
Drug,spironolactone 100mg,1
Drug,standard of care therapy,1
Drug,standard of care thromboprophylaxis,1
Drug,standard therapy,1
Drug,standard therapy for covid-19 according to the stablished hospital protocols.,1
Drug,standard therapy of covid-19,1
Drug,standards of care,1
Drug,stannous protoporphyrin (90mg),1
Drug,stem cell product,1
Drug,sterile normal saline for intravenous use,1
Drug,sterile water for injection,1
Drug,t3 solution for injection,1
Drug,t89,1
Drug,tacrolimus,1
Drug,tcm prescriptions,1
Drug,td-0903,1
Drug,telmisartan 40mg,1
Drug,telmisartan arm will receive 80 mg telmisartan twice daily plus standard care.,1
Drug,tetrandrine,1
Drug,therapeutic anticoagulation,1
Drug,thiazide or thiazide-like diuretics,1
Drug,thromboprophylaxis,1
Drug,thromboprophylaxis with low-molecular-weight heparin or fondaparinux,1
Drug,thymosin alpha 1,1
Drug,thymosin+standard treatment,1
Drug,tinzaparin or unfractionated heparin,1
Drug,tirofiban injection,1
Drug,tj003234,1
Drug,tociliuzumab,1
Drug,tocilizumab 20 mg/ml intravenous solution [actemra],1
Drug,tofacitinib,1
Drug,tradipitant,1
Drug,traditional chinese medicine prescription,1
Drug,tranexamic acid,1
Drug,tranexamic acid tablets,1
Drug,transfusion of covid-19 convalescent plasma,1
Drug,treatment and prophylaxis,1
Drug,treatment with dexmedetomidine,1
Drug,trimethoprim/sulfamethoxazole,1
Drug,umifenovir,1
Drug,unikinon (chloroquine phosphate) 200mg tablets,1
Drug,usual care and no colchine,1
Drug,valsartan (diovan),1
Drug,vazegepant (bhv-3500),1
Drug,vc,1
Drug,verapamil,1
Drug,xiyanping injection,1
Drug,yin hu qing wen granula(low does),1
Drug,yinhu qingwen decoction,1
Drug,yinhu qingwen decoction(low dose),1
Drug,yinhu qingwen granula,1
Drug,zithromax oral product,1
Genetic,mesenchymal stromal cells,1
Genetic,next generation sequencing (ngs) analysis,1
Genetic,sars-cov-2 viral composition,1
Genetic,sequencing,1
Genetic,t-cell receptor (tcr) repertoire,1
Genetic,whole genome analysis,1
Other,- synthetic anti-malarial drugs,1
Other,"""calm"" is a mindfulness meditation mobile app",1
Other,(standard of care) soc,1
Other,1: usual practice,1
Other,2d telemedicine,1
Other,3d telemedicine,1
Other,40ml blood sample,1
Other,additional biological samples,1
Other,additional blood tubes,1
Other,all treatment about covid-2019,1
Other,anti-sars-cov-2 convalescent plasma,1
Other,antibody-rich plasma from covid-19 recovered patients,1
Other,assessment of postnatal depression using the the edinburgh questionnaire between 4 and 6 weeks after delivery,1
Other,assessment of the presence of the sars-cov-2 virus,1
Other,auto-questionnaires (patients co infected hiv sras-cov-2),1
Other,bacterial species isolated,1
Other,basic treatment,1
Other,best available therapy,1
Other,best practice,1
Other,best standard of care,1
Other,biological samples collection,1
Other,biomarkers in the long term impact of coronavirus infection in the cardiorrespiratory system,1
Other,biomedomics covid-19 igm-igg rapid test,1
Other,blood and derivatives.,1
Other,blood donation from convalescent donor,1
Other,blood samples,1
Other,brief psychiatric rating scale,1
Other,cardiac and electrodermal recordings,1
Other,cardiac surgery,1
Other,cash transfer,1
Other,chinese medicine treatment,1
Other,clinical diagnosis of covid-19 by a health care professional,1
Other,comprehensive treatment,1
Other,connor-davidson resilience scale 10 items (cd-risc 10),1
Other,continuation of acei/arb,1
Other,continuation of arb/acei,1
Other,control,1
Other,control group,1
Other,convalescent plasma from recovered covid 19 donor,1
Other,conventional management of patients,1
Other,covid-19 igm-igg rapid test,1
Other,covid-19 infection,1
Other,covid-19 pandemic,1
Other,cross-sectional observational study,1
Other,cross-sectional study investigating the association of npis with mental health,1
Other,ct score,1
Other,current care per ucla treating physicians,1
Other,daily syndromic surveillance,1
Other,data collection,1
Other,data record,1
Other,deep venous disease diagnostic,1
Other,"depression, anxiety and stress scale",1
Other,"determination of physical activity, quality of life, stress levels of isolated people at home with the danger of coronavirus.",1
Other,discontinuation of acei/arb,1
Other,discontinuation of arb/acei,1
Other,doppler echo,1
Other,echocardiography,1
Other,equipment with smartwatch throughout hospital stay on the general ward,1
Other,evaluate hacor score effectivity in this patients,1
Other,evaluation of the epidemiological characteristics of coronavirus infection (sars-cov-2),1
Other,experimental: questionnaire without precaution information,1
Other,exposed to the novel coronavirus disease 2019,1
Other,exposure,1
Other,exposure (not intervention) - sars-cov-2 infection,1
Other,exposure to the sars-cov-2 and its consequences,1
Other,extra blood sample,1
Other,fibrin generation markers assays,1
Other,gad-7 (7-item generalized anxiety disorder),1
Other,gas exchanges at different peep,1
Other,global survey,1
Other,"gps reports of potential patient safety incidents, non-covid-19 related",1
Other,hemodynamics changes at different peep,1
Other,home-cov rule implementation,1
Other,home care monitoring,1
Other,hospital anxiety and depression scale,1
Other,hospitalized children with covid19,1
Other,human biological samples,1
Other,hydroxychloroquine/chloroquine,1
Other,hyperimmune plasma,1
Other,"hypoxia : 14.3 and 12.7% fio2, hypercapnia 7% co2, inspiratory mechanical constraint",1
Other,icu treatment,1
Other,immunological profiling,1
Other,impact event score,1
Other,impact of event scale-revised,1
Other,individualised ayurveda,1
Other,inhaled supplemental oxygen,1
Other,injective placebo,1
Other,interview,1
Other,intravenous saline injection (placebo),1
Other,it is a survey,1
Other,liver injury,1
Other,local standard of care,1
Other,lung mechanics at different peep,1
Other,maslach burnout inventory questionnair,1
Other,matched placebo hydroxychloroquine,1
Other,maximal effort test,1
Other,mobile internet survey on self-test,1
Other,modification of the planned therapeutic management,1
Other,monitoring for aggravation,1
Other,na (no intervention),1
Other,nacl 0.9%,1
Other,nasal swab,1
Other,"ncapp, a cell phone-based auto-diagnosis system",1
Other,newborns from covid 19 positive mothers,1
Other,no intervention (survey study for medical doctors).,1
Other,no interventional study,1
Other,no special intervention,1
Other,non,1
Other,non-interventional,1
Other,none - na,1
Other,nosocomial infection/hospital acquired infection,1
Other,nutrition support,1
Other,observation,1
Other,"observation of patients with known, suspected, or at risk for covid-19 infection",1
Other,observational only,1
Other,observational study,1
Other,olfactory and gustatory tests,1
Other,on-line survey,1
Other,online survey,1
Other,oral placebo,1
Other,others(no intervention),1
Other,"oxygen-ozone therapy, probiotic supplementation and standard of care",1
Other,oxygen therapy,1
Other,oxygen treatment,1
Other,ozone therapy group (covid positive),1
Other,patient management suffering of coronavirus infection,1
Other,patient sampling,1
Other,peep trial,1
Other,phq-9 (9-item patient health questionnaire),1
Other,phsyiotherapy,1
Other,physiological serum,1
Other,placebo + placebo,1
Other,placebo oral tablet,1
Other,plasma donation,1
Other,plasma therapy using convalescent plasma with antibody against sars-cov-2,1
Other,postpartum women under investigation for coronavirus or diagnosed with covid-19,1
Other,postural positioning,1
Other,practice details,1
Other,pregnant women under investigation for coronavirus or diagnosed with covid-19,1
Other,"primary care professionals reports of potential patient safety incidents, non-covid-19 related",1
Other,prone,1
Other,prone decubitus,1
Other,prone position,1
Other,prone positioning,1
Other,prospective oberservational registry,1
Other,protective ventilation,1
Other,pss (perceived stress scale),1
Other,psycho-education video,1
Other,psychoeducational intervention,1
Other,pulmonary physiotherapy techniques,1
Other,pulmonary ultrasound,1
Other,qualitative interviews (in 40 patients : 20 with covid-19 and 20 without covid-19),1
Other,quality of life,1
Other,quesionnair,1
Other,questionnair about emerging legal and ehical disputes over patient confidentiality,1
Other,questionnaire by phone call,1
Other,questionnaire with precaution information,1
Other,"questionnaires, spirometry",1
Other,quetionnary,1
Other,rapid molecular test,1
Other,rehabilitation,1
Other,retrospective data collection,1
Other,routine care for covid-19 patients,1
Other,saline,1
Other,saline nasal irrigation,1
Other,saline with baby shampoo nasal irrigation,1
Other,samling of oropharynx and nasopharynx,1
Other,sars-cov-2 infection,1
Other,satisfaction evaluation,1
Other,self-administered questionnaires,1
Other,self-prone position recommendation,1
Other,serological test,1
Other,serum chemistry analysis,1
Other,severe covid-19 pneumonia with et,1
Other,simulation of repurposed drugs for covid-19,1
Other,speq (specific psychotic experiences questionnaire) - paranoia and grandiosity subscales,1
Other,spin-chat program,1
Other,standar of care,1
Other,standard administration of oxygen flow,1
Other,standard interface,1
Other,standard medical care,1
Other,standard medical treatment,1
Other,standard of care treatment,1
Other,standard operating procedures,1
Other,standard public health measures,1
Other,standard supportive care,1
Other,standard western medicine treatment,1
Other,study a,1
Other,study b,1
Other,study c,1
Other,study group,1
Other,supportive care,1
Other,surgical facial mask,1
Other,survey administration,1
Other,survey group,1
Other,suspension or maintenance of angiotensin receptor blockers and angiotensin-converting enzyme inhibitors,1
Other,symptoms questionnare,1
Other,systemic indirect endovenous ozone therapy,1
Other,taste and olfactory function evaluation,1
Other,tele-medicine platform,1
Other,telehealth,1
Other,telehealth applications,1
Other,telephone survey,1
Other,tested for sars-cov-2 (regardless of the result),1
Other,the control group will not receive hydroxychloroquine,1
Other,there is no intervention in this study,1
Other,this study is non- interventional,1
Other,thrombin generation test assay,1
Other,ultraprotective ventilation,1
Other,usual antibiotic treatment,1
Other,venous ultrasound,1
Other,video based aerobic exercise,1
Other,vitamin c,1
Other,washed microbiota transplantation,1
Other,web-based redcap survey,1
Other,weekly assessment,1
Other,zaritt burden interview,1
Other,zinc levels,1
Procedure,alveolar recruitment,1
Procedure,auricular neuromodulation,1
Procedure,awake proning,1
Procedure,biological samples specific to research,1
Procedure,blood draw,1
Procedure,blood sampling,1
Procedure,chest physiotherapy using a non-invasive oscillating device,1
Procedure,clinical examination,1
Procedure,combined use of a respiratory broad panel multiplex pcr and procalcitonin,1
Procedure,continuous renal replacement therapy,1
Procedure,control,1
Procedure,conventional oxygen,1
Procedure,cpap,1
Procedure,ct-scan with minimal invasive autopsy,1
Procedure,direct laryngoscopy,1
Procedure,double gloves,1
Procedure,ecmo implantation,1
Procedure,extended sampling and procedures,1
Procedure,facial fractures reduction or osteosynthesis,1
Procedure,follow-up at 14 days,1
Procedure,hfno,1
Procedure,human biological samples,1
Procedure,iv deployment of csvf in sterile normal saline iv solution,1
Procedure,lung ultrasound,1
Procedure,mechanical ventilation,1
Procedure,microcannula harvest adipose derived tissue stromal vascular fraction (tsvf),1
Procedure,peripheral blood draw,1
Procedure,prone position,1
Procedure,prone positioning (pp),1
Procedure,standard of care.,1
Procedure,standard procedure,1
Procedure,standard therapy recommended by the ministry of health of the russian federation and dalargin inhalation,1
Procedure,standard therapy recommended by the ministry of health of the russian federation and dalargin intramuscular injection,1
Procedure,standard therapy recommended by the ministry of health of the russian federation and dalargin intramuscular injection combined with dalargin inhalation,1
Procedure,standard therapy recommended by the ministry of health of the russian federation.,1
Procedure,surgery,1
Procedure,telephone follow-up,1
Procedure,vascular surgery,1
Procedure,vie scope laryngoscopy,1
Radiation,low dose radiation therapy,1
